To address the role of tau hyperphosphorylation and NFT formation in AD pathogenesis, human MAPT (TAU) has been introduced into the mouse genome, either mutated or non-mutated, on a tau-knockout background8,9. Here, MAPT is linked to Alzheimer disease.